(CLH) Clean Harbors - Overview
Stock: Waste Management, Industrial Cleaning, Lubricant Products, Recycling Services
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 25.1% |
| Relative Tail Risk | -8.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | -2.84 |
| Character TTM | |
|---|---|
| Beta | 0.763 |
| Beta Downside | 0.641 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.86% |
| CAGR/Max DD | 0.83 |
Description: CLH Clean Harbors January 03, 2026
Clean Harbors, Inc. (NYSE: CLH) delivers environmental and industrial services across the U.S. and Canada through two primary segments. The Environmental Services segment handles the full waste lifecycle-collection, transport, treatment, and disposal of hazardous and non-hazardous materials, including specialized services such as incineration, landfill disposal, wastewater treatment, laboratory chemical handling, and explosives management. The Safety-Kleen Sustainability Solutions segment focuses on containerized waste, parts-washer, and vacuum services for automotive, industrial, and retail customers, and also manufactures and packages lubricants and related products.
Key recent metrics: FY 2023 revenue reached roughly $5.1 billion, with adjusted EBITDA margin around 13%, and the company reported a 5% year-over-year increase in hazardous waste volumes-driven by tighter environmental regulations and continued demand from the oil-and-gas sector. Capital expenditures have been directed toward expanding its waste-to-energy facilities, a sector trend that can improve margin resilience as energy prices rise. The balance sheet remains strong, with a net debt-to-EBITDA ratio near 2.2×, providing flexibility for strategic acquisitions.
For a deeper, data-driven valuation framework, you may find the CLH analysis on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 388.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.20 > 1.0 |
| NWC/Revenue: 25.84% < 20% (prev 21.26%; Δ 4.58% < -1%) |
| CFO/TA 0.11 > 3% & CFO 815.6m > Net Income 388.4m |
| Net Debt (-498.7m) to EBITDA (1.12b): -0.45 < 3 |
| Current Ratio: 2.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.7m) vs 12m ago -0.95% < -2% |
| Gross Margin: 31.11% > 18% (prev 0.31%; Δ 3080 % > 0.5%) |
| Asset Turnover: 80.32% > 50% (prev 79.35%; Δ 0.97% > 0%) |
| Interest Coverage Ratio: 4.11 > 6 (EBITDA TTM 1.12b / Interest Expense TTM 163.5m) |
Altman Z'' 3.64
| A: 0.20 (Total Current Assets 2.61b - Total Current Liabilities 1.07b) / Total Assets 7.54b |
| B: 0.35 (Retained Earnings 2.67b / Total Assets 7.54b) |
| C: 0.09 (EBIT TTM 671.4m / Avg Total Assets 7.42b) |
| D: 0.52 (Book Value of Equity 2.46b / Total Liabilities 4.76b) |
| Altman-Z'' Score: 3.64 = AA |
Beneish M -3.13
| DSRI: 0.96 (Receivables 1.29b/1.30b, Revenue 5.96b/5.80b) |
| GMI: 1.00 (GM 31.11% / 31.25%) |
| AQI: 0.94 (AQ_t 0.29 / AQ_t-1 0.31) |
| SGI: 1.03 (Revenue 5.96b / 5.80b) |
| TATA: -0.06 (NI 388.4m - CFO 815.6m) / TA 7.54b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of CLH shares?
Over the past week, the price has changed by +0.15%, over one month by +9.31%, over three months by +20.71% and over the past year by +8.96%.
Is CLH a buy, sell or hold?
- StrongBuy: 7
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CLH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 266.4 | 2.5% |
| Analysts Target Price | 266.4 | 2.5% |
| ValueRay Target Price | 312.7 | 20.3% |
CLH Fundamental Data Overview January 27, 2026
P/E Forward = 32.8947
P/S = 2.3344
P/B = 4.9953
P/EG = 188.43
Revenue TTM = 5.96b USD
EBIT TTM = 671.4m USD
EBITDA TTM = 1.12b USD
Long Term Debt = 2.76b USD (from longTermDebt, last quarter)
Short Term Debt = 15.1m USD (from shortLongTermDebt, last quarter)
Debt = 260.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -498.7m USD (from netDebt column, last quarter)
Enterprise Value = 13.42b USD (13.92b + Debt 260.5m - CCE 759.2m)
Interest Coverage Ratio = 4.11 (Ebit TTM 671.4m / Interest Expense TTM 163.5m)
EV/FCF = 30.30x (Enterprise Value 13.42b / FCF TTM 442.9m)
FCF Yield = 3.30% (FCF TTM 442.9m / Enterprise Value 13.42b)
FCF Margin = 7.43% (FCF TTM 442.9m / Revenue TTM 5.96b)
Net Margin = 6.51% (Net Income TTM 388.4m / Revenue TTM 5.96b)
Gross Margin = 31.11% ((Revenue TTM 5.96b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 32.33% (prev 33.32%)
Tobins Q-Ratio = 1.78 (Enterprise Value 13.42b / Total Assets 7.54b)
Interest Expense / Debt = 13.71% (Interest Expense 35.7m / Debt 260.5m)
Taxrate = 26.13% (42.0m / 160.8m)
NOPAT = 495.9m (EBIT 671.4m * (1 - 26.13%))
Current Ratio = 2.44 (Total Current Assets 2.61b / Total Current Liabilities 1.07b)
Debt / Equity = 0.09 (Debt 260.5m / totalStockholderEquity, last quarter 2.78b)
Debt / EBITDA = -0.45 (Net Debt -498.7m / EBITDA 1.12b)
Debt / FCF = -1.13 (Net Debt -498.7m / FCF TTM 442.9m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.23% (Net Income 388.4m / Total Assets 7.54b)
RoE = 14.61% (Net Income TTM 388.4m / Total Stockholder Equity 2.66b)
RoCE = 12.38% (EBIT 671.4m / Capital Employed (Equity 2.66b + L.T.Debt 2.76b))
RoIC = 9.11% (NOPAT 495.9m / Invested Capital 5.44b)
WACC = 8.76% (E(13.92b)/V(14.18b) * Re(8.73%) + D(260.5m)/V(14.18b) * Rd(13.71%) * (1-Tc(0.26)))
Discount Rate = 8.73% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.50%
[DCF Debug] Terminal Value 78.84% ; FCFF base≈373.3m ; Y1≈460.2m ; Y5≈783.0m
Fair Price DCF = 224.0 (EV 11.47b - Net Debt -498.7m = Equity 11.97b / Shares 53.4m; r=8.76% [WACC]; 5y FCF grow 24.94% → 2.90% )
EPS Correlation: -21.45 | EPS CAGR: -37.26% | SUE: -4.0 | # QB: 0
Revenue Correlation: 85.49 | Revenue CAGR: 9.05% | SUE: -0.75 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.22 | Chg30d=+0.020 | Revisions Net=+2 | Analysts=7
EPS next Year (2026-12-31): EPS=8.04 | Chg30d=+0.046 | Revisions Net=+1 | Growth EPS=+10.8% | Growth Revenue=+3.9%